Almost similar levels of IFN-γ secretion or IFN-γ spots were seen in ALS patients’ NK cells with IL-2 alone, IL-2 + anti-CD16 mAbs, or IL-2 + sAJ2 treatments (Figure 2c–f). The gene discussed is IFNG; the disease is amyotrophic lateral sclerosis.